Estimated antiretroviral therapy coverage among people living with HIV in Sur
Sur: Estimated antiretroviral therapy coverage among people living with HIV was 50.0% in 2025. ◆ Volatile
Estimated antiretroviral therapy coverage among people living with HIV in Sur, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Sur recorded 50.0% for estimated antiretroviral therapy coverage among people living with hiv in 2025. That is the highest value across all 26 years on record.
The figure is up 2.0% on the previous year and up 38.9% over ten years.
Over the whole period, estimated antiretroviral therapy coverage among people living with hiv in Sur peaked at 50.0% in 2025 and was at its lowest, 0.0%, in 2000.
The series is highly variable year to year, so single readings are best treated with caution.
Estimated antiretroviral therapy coverage among people living with HIV in Sur, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 1.0% | — |
| 2003 | 3.0% | +200.0% |
| 2004 | 5.0% | +66.7% |
| 2005 | 7.0% | +40.0% |
| 2006 | 10.0% | +42.9% |
| 2007 | 13.0% | +30.0% |
| 2008 | 16.0% | +23.1% |
| 2009 | 18.0% | +12.5% |
| 2010 | 20.0% | +11.1% |
| 2011 | 23.0% | +15.0% |
| 2012 | 28.0% | +21.7% |
| 2013 | 32.0% | +14.3% |
| 2014 | 35.0% | +9.4% |
| 2015 | 36.0% | +2.9% |
| 2016 | 39.0% | +8.3% |
| 2017 | 40.0% | +2.6% |
| 2018 | 41.0% | +2.5% |
| 2019 | 40.0% | -2.4% |
| 2020 | 47.0% | +17.5% |
| 2021 | 44.0% | -6.4% |
| 2022 | 41.0% | -6.8% |
| 2023 | 49.0% | +19.5% |
| 2024 | 49.0% | +0.0% |
| 2025 | 50.0% | +2.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 7.3% | 0.0% | 18.0% | 10 |
| 2010s | 33.4% | 20.0% | 41.0% | 10 |
| 2020s | 46.7% | 41.0% | 50.0% | 6 |
Countries ranked near Sur
- 1 Botswana 98.0% compare
- 2 Saudi Arabia 97.0% compare
- 2 Sao Tome and Principe 97.0% compare
- 4 Lesotho 96.0% compare
More health data for Sur
- Pertussis - number of reported cases, gaps filled 8 (2025)
- Total tetanus - number of reported cases, gaps filled 0 (2025)
- Diphtheria - number of reported cases, gaps filled 0 (2025)
- Measles - number of reported cases, gaps filled 0 (2025)
- Measles - number of reported cases, annual growth rate -100 % change on previous year (1991)
- Pertussis - number of reported cases, annual growth rate -100 % change on previous year (2023)
- Total tetanus - number of reported cases, annual growth rate -100 % change on previous year (2021)
- Total tetanus - number of reported cases 0 (2025)
- Measles - number of reported cases 0 (2025)
- Diphtheria - number of reported cases 0 (2025)
Frequently asked questions
- What is estimated antiretroviral therapy coverage among people living with hiv in Sur?
- Estimated antiretroviral therapy coverage among people living with hiv in Sur was 50.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest estimated antiretroviral therapy coverage among people living with hiv recorded in Sur?
- The highest recorded value was 50.0% in 2025.
- What is the lowest estimated antiretroviral therapy coverage among people living with hiv recorded in Sur?
- The lowest recorded value was 0.0% in 2000.
- How does Sur rank for estimated antiretroviral therapy coverage among people living with hiv?
- Sur ranks 1st out of 2 regions with data for 2025.
- Is estimated antiretroviral therapy coverage among people living with hiv rising or falling in Sur?
- Over the last ten years it is up 38.9%. The long-run trend across the full record is volatile.
- Where does this Sur data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).